HARRISONS MALAYALAM
|
HARRISONS MALAYALAM Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 8.07 | -3.96 | 9.63 | 12.51 | 21.90 |
| CEPS(Rs) | 12.04 | -0.83 | 11.99 | 14.80 | 24.13 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 83.52 | 77.97 | 84.62 | 74.77 | 62.32 |
| Tax Rate(%) | - | - | - | - | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 4.57 | 2.14 | 5.60 | 6.65 | 12.26 |
| EBIT Margin(%) | 5.44 | 1.20 | 6.16 | 7.27 | 11.97 |
| Pre Tax Margin(%) | 2.90 | -1.50 | 3.65 | 4.90 | 8.96 |
| PAT Margin (%) | 2.90 | -1.50 | 3.65 | 4.90 | 8.96 |
| Cash Profit Margin (%) | 4.32 | -0.31 | 4.55 | 5.79 | 9.87 |
| Performance Ratios | |||||
| ROA(%) | 3.18 | -1.39 | 3.09 | 4.16 | 7.40 |
| ROE(%) | 9.99 | -4.87 | 12.08 | 18.25 | 41.70 |
| ROCE(%) | 11.38 | 2.40 | 12.71 | 15.76 | 26.77 |
| Asset Turnover(x) | 1.10 | 0.93 | 0.85 | 0.85 | 0.83 |
| Sales/Fixed Asset(x) | 1.54 | 1.50 | 1.55 | 1.54 | 1.49 |
| Working Capital/Sales(x) | -4.19 | -3.73 | -5.10 | -5.42 | -4.76 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.65 | 0.67 | 0.65 | 0.65 | 0.67 |
| Receivable days | 11.26 | 11.15 | 9.32 | 11.43 | 9.81 |
| Inventory Days | 26.76 | 27.95 | 27.26 | 27.01 | 30.51 |
| Payable days | 125.68 | 135.08 | 125.25 | 108.59 | 123.24 |
| Valuation Parameters | |||||
| PER(x) | 25.21 | - | 11.18 | 10.55 | 6.35 |
| PCE(x) | 16.89 | -198.82 | 8.97 | 8.92 | 5.76 |
| Price/Book(x) | 2.44 | 2.12 | 1.27 | 1.77 | 2.23 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.92 | 0.81 | 0.59 | 0.69 | 0.78 |
| EV/Core EBITDA(x) | 13.40 | 20.68 | 8.40 | 8.46 | 6.03 |
| EV/EBIT(x) | 16.92 | 67.95 | 9.62 | 9.50 | 6.49 |
| EV/CE(x) | 1.87 | 1.67 | 1.16 | 1.45 | 1.66 |
| M Cap / Sales | 0.73 | 0.62 | 0.41 | 0.52 | 0.57 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 5.28 | 0.28 | 3.23 | 4.53 | 16.48 |
| Core EBITDA Growth(%) | 84.05 | -44.15 | -10.74 | -33.77 | 97.24 |
| EBIT Growth(%) | 379.15 | -80.53 | -12.46 | -36.56 | 114.64 |
| PAT Growth(%) | 303.86 | -141.11 | -23.05 | -42.88 | 336.42 |
| EPS Growth(%) | 303.86 | -141.11 | -23.05 | -42.88 | 336.42 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.65 | 0.65 | 0.59 | 0.62 | 0.83 |
| Current Ratio(x) | 0.41 | 0.40 | 0.70 | 0.73 | 0.71 |
| Quick Ratio(x) | 0.22 | 0.23 | 0.59 | 0.62 | 0.60 |
| Interest Cover(x) | 2.14 | 0.44 | 2.45 | 3.07 | 3.97 |
| Total Debt/Mcap(x) | 0.27 | 0.31 | 0.46 | 0.35 | 0.37 |
Compare Financial Ratios of peers of HARRISONS MALAYALAM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HARRISONS MALAYALAM | ₹322.8 Cr | 1.9% | -14.2% | -31.1% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,796.5 Cr | -1.4% | -9.1% | -27% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,106.4 Cr | 4.4% | -5.8% | 10.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,895.5 Cr | 0.6% | -8.5% | -21.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,102.7 Cr | -6.5% | -14.2% | -26.4% | Stock Analytics | |
| INDO US BIOTECH | ₹272.8 Cr | 16.7% | -3.5% | -40.7% | Stock Analytics | |
HARRISONS MALAYALAM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HARRISONS MALAYALAM | 1.9% |
-14.2% |
-31.1% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses
